Japanese herbal medicine TJ-48 prevents autoimmune diabetes in NOD mice

American Journal of Chinese Medicine

Volumn 39, Issue 4, 2011, Pages 743-756

  Ikemoto, Tetsuya ^a,b   Sugimoto, Koji ^a,b   Takita, Morihito ^a   Shimoda, Masayuki ^c   Noguchi, Hirofumi ^a   Naziruddin, Bashoo ^d   Levy, Marlon F ^d   Shimada, Mitsuo ^b   Matsumoto, Shinichi ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

Autoimmunity; NOD Mice; Regulatory T Cell; TJ 48

Indexed keywords

SHI QUAN DA BU TANG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GLUCOSE BLOOD LEVEL; HISTOLOGY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE;

ANGIOSPERMS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUGS, CHINESE HERBAL; FASTING; FEMALE; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MEDICINE, EAST ASIAN TRADITIONAL; MICE; MICE, INBRED NOD; PHYTOTHERAPY; POLYPORACEAE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79960016568     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009160     Document Type: Article

References (19)

1. Chen, Z., A.E. Herman, M. Matos, D. Mathis and C. Mathis. Where CD4CD25 T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202: 1387-1397, 2006.
2. Dai, Y., M. Kato, K. Takeda, Y. Kawamoto, A.A. Akhand, K. Hossain, H. Suzuki and I. Nakashima. T-cell-immunity-based inhibitory effects of orally administrated herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumor in RET-transgenic mice. J. Invest. Dermatol. 117: 694-701, 2001. (Pubitemid 32955600)
3. Fujiki, K., M. Nakamura, T. Matsuda, et al., IL-12 and IL-18 induction and subsequent NKT activation effects of Japanese botanical medicine Juzentaihoto. Int. J. Mol. Sci. 9: 1142-1155, 2008.
4. Hori, S., T. Nomura and S. Sakaguchi. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003. (Pubitemid 36222930)
5. Hosokawa, Y. Radioprotective effects of Chinese medical prescriptions in mice. J. Med. Pharm. Soc. 3: 164-169, 1986.
6. Ikemoto, T., S. Matsumoto, M. Shimoda, et al. Islet cell transplantation for the treatment of type 1 diabetes in USA. J. Hepatobiliary Pancreat. Surg. 16: 118-123, 2009.
7. Ikemoto, T., M. Shimada, T. Utsunomiya, S. Imura, Y. Morine, H. Mori, J. Hanaoka, S. Iwahashi, Y. Saito and S. Yamada. Immunoaugumentation of Japanese Kampo medicine, Juzen-Taihoto/ TJ-48, in patients with advanced pancreatic cancer. Kampo Sequre 138: 29-30, 2011 (in Japanese).
8. Joffre, O., T. Santolaria, D. Calise, T. Al Saati, D. Hudrisier, P. Romagnoli and J.P. Van Meerwijk. Prevention of acute and chronic allograft rejection with CD4\+CD25\+Foxp3\+ regulatory T lymphocytes. Nat. Med. 14: 88-92, 2008.
9. Knip, M. and H. Siljander. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 7: 550-557, 2008.
10. Kogure, T., K. Itoh, T. Tatsumi, N. Sekiya, S. Sakai, Y. Shimada, J. Tamura and K. Terasawa. The effect of Juzen-taiho-to/TJ48 on the expression of killer-cell immunoglobulin-like receptors (CD158a/b) on peripheral lymphocytes in vitro experiment. Phytomedicine 12: 327-332, 2005. (Pubitemid 40615327)
11. Liu, H., J. Wang, A. Sekiyama and T. Tabira. Juzen-taiho-to, an herbal medicine, activates and enhances phagocytosis in microglia/macrophages. Tohoku Exp. Med. 215: 43-54, 2008. (Pubitemid 351791267)
12. Munn, D.H. and A.L. Mellor. Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117: 1147-1154, 2007.
13. Ogasawara, K., J.A. Hamerman, L.R. Ehrlich, H. Bour-Jordan, P. Santamaria, J.A. Bluestone and L.L. Lanier. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20: 757-767, 2004. (Pubitemid 38757445)
14. Pinkse, G.G., O.H. Tysma, C.A. Bergen, M.G. Kester, F. Ossendorp, P.A. Van Veelen, B. Key-meulen, D. Pipeleers, J.W. Drijghout and B.O. Roep. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. USA 102: 18425-18430, 2005. (Pubitemid 43011242)
15. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh and M. Toda. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164, 1995.
16. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe and J.A. Bluestone. B7/ CD28 costimulation is essential for the homeostasis of the CD4\+CD25\+ immunoregulatory T cells that control autoimmune diabetes. Immunity 212: 431-440, 2000.
17. Sgouroudis, E. and C.A. Piccirillo. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lesson from mouse models and implications for human diabetes. Diabetes Metab. Res. Rev. 25: 208-218, 2009.
18. Sho, Y., K. Fujisaki, H. Sakashita, K. Yamaguchi, K. Tahara, O. Kubozono, A. Ido and H. Tsu-bouchi. Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J. Gastroenterol. 39: 1202-1204, 2004. (Pubitemid 40074288)
19. Wood, K.J. and S. Sakaguchi. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210, 2003. (Pubitemid 37323205)